key: cord-0845759-80z2bpgz authors: Jones, Rachel K.; Lindberg, Laura; Witwer, Elizabeth title: COVID‐19 Abortion Bans and Their Implications for Public Health date: 2020-05-14 journal: Perspect Sex Reprod Health DOI: 10.1363/psrh.12139 sha: 3e773d99eb0ec73c500f2da0c1407b7a059bd2e2 doc_id: 845759 cord_uid: 80z2bpgz nan Abortion is essential health care. Claims that it is ‚nonessential‛ contradict guidance from leading medical experts and public health organizations. The American College of Obstetricians and Gynecologists (ACOG), along with numerous other medical associations, recently issued a joint statement asserting that abortion remains an essential and time-sensitive service during the COVID-19 crisis. 2 For example, the inability to terminate a pregnancy in a timely manner can increase the need for abortions at later gestations, when they are more expensive and, despite the safety of abortion, pose a greater health risk than first-trimester procedures. 3 Indeed, carrying a pregnancy to term has its own risks, as the risk of mortality associated with childbirth is 14 times as high as for abortion. 4 Reinforcing the ACOG joint statement, the American Medical Association (AMA) issued a statement that condemned government intrusion in the decision of what qualifies as ‚urgent‛ health care during the pandemic. 5 They expressed concern that the motivations of elected officials may be rooted less in best medical practices and, instead, are ‚exploiting this moment to ban or dramatically limit women's reproductive health care.‛ Finally, beyond the fact that medical authorities have asserted that abortion is essential and time-sensitive, the claim that abortion procedures strain the supply of PPE is inaccurate and misleading. First-trimester in-clinic procedures require very little PPE, and the provision of medication abortion-which accounts for at least one-third of all abortions in the country 6can be safely offered with virtually no use of PPE. 7 As of May 12, 2020, at least 11 states have attempted to restrict access to abortion by deeming it to be nonessential. These include Alabama, Alaska, Arkansas, Iowa, Kentucky, Louisiana, Ohio, Oklahoma, Tennessee, Texas and West Virginia. All but Alaska are located in the Midwest and the South, regions of the country that have passed the most abortion restrictions over the last 10 years. 6 Texas, for example, has a history of restrictive legislation that had curtailed access to abortion prior to the COVID-19 pandemic. In July of 2013, Texas passed House Bill 2, which imposed such harsh restrictions that nearly half of the state's 41 facilities providing abortions closed. 8 there is no evidence that these types of policies contribute to patient health and well-being; quite the opposite, in fact, as evidence demonstrates that restrictions can contribute to negative consequences for the individuals impacted by them. 9 Furthermore, major medical groups such as ACOG and the AMA, as well as the APHA, oppose these restrictions. 9 While the public health landscape shifts in the wake of the pandemic, Texas and other states continue in the familiar and troubling trend of attempting to restrict abortion with no scientific grounding. Researchers are in the process of empirically assessing the impact of such bans on individuals seeking abortion care, but we can draw on prior research to understand what many are likely experiencing during the pandemic. In states where abortion bans are currently imposed, the options are for individuals to travel out of state for the procedure, continue the pregnancy and hope they will be able to access abortion care when the ban is no longer in place, attempt to selfmanage an abortion outside a formal medical setting (e.g., by purchasing abortion drugs on the Internet) or carry the pregnancy to term. Travel may not be a realistic option for many needing to access abortion care. Prior to the pandemic, women in Texas had to travel an average of 12 miles to reach the nearest clinic; if all abortion clinics in the state were to close, per the intent of those pursuing a COVID-19 abortion ban, people would have to travel an average of 243 miles to reach the nearest facility in the neighboring states. 10 The increased costs posed by additional travel will likely be a barrier to care as well. Nationally, three-quarters of abortion patients are poor or low-income, and the majority have one or more children. 11 Even in the absence of a pandemic, many women struggle to come up with the money to pay for the procedure, and this can delay timely care. 12, 13 Under the current circumstances, economic obstacles are further compounded by a record high rate of unemployment and reductions in work hours, as well as loss (or lack) of health insurance. Moreover, many individuals needing abortions may now have young children schooling at home. Raising additional funds to cover the costs of travel and lodging, as well as finding childcare, will pose insurmountable obstacles to many individuals. Evidence from Texas following the implementation of the admitting-privileges law House Bill 2 found that all of these costs increased for women when about half the state's abortion clinics closed. 14 Moreover, the number of abortions in Texas decreased as travel distance increased, 15 and there was a 40% increase in secondtrimester procedures. 16 All these factors suggest that new abortion bans will result in fewer abortions, an increase in second-trimester abortions and, for those ultimately unable to access care, more births from unintended pregnancies. Complicating this situation is the potential that heightened economic instability will actually increase the number of individuals desiring an abortion if women feel that they do not have the money to support a(nother) child, as this is a frequently reported motivation for abortion even in better economic times. 17 Short-term barriers to accessing abortion during the current pandemic are likely to have long-term negative effects. Longitudinal research among U.S. women who were unable to obtain wanted abortions found that, compared with individuals who had terminated a pregnancy, those who had been denied an abortion and forced to carry to term experienced more debt, had lower credit scores 18 and were more likely to have poverty-level incomes four or more years later. 19 They also experienced more chronic pain, had worse self-reported health 20 and were more likely to experience sustained physical violence from the man involved in the pregnancy. 21 The rights and health of all pregnant individuals are compromised by policies that ban or limit access to abortion under the guise of a public health response to COVID-19. These policies represent one more way in which the racial and social inequities of this pandemic are playing out. Poor and marginalized women, and This article is protected by copyright. All rights reserved. Accepted Article women of color, are more likely to need access to abortion care. 11 Moreover, research has shown that black women and those with limited financial resources already face numerous economic and structural hurdles that delay access to abortion. 3 The restrictions currently being implemented-or proposed-will exacerbate these hurdles and delay access to timely care, thereby pushing individuals past the gestational limits for an abortion in many states and, ultimately, make abortion inaccessible. For individuals who are able to travel out of state for abortion care, facilities in neighboring states may be unable to meet increased demand. Prior to the COVID-19 pandemic, it was challenging for many clinics to provide care for their normal patient flow, as they had to adhere to multiple restrictions that increase the cost of 23 Similarly, we fear that COVID-19-related bans are likely to reduce access to care even after they are lifted. Several of these legal challenges are still moving through the courts, and later surges in COVID-19 caseloads may necessitate further emergency health care responses. Some clinics may find themselves unable to sustain operations in an environment with on-again/off-again cycles of services. Even in states that have not attempted to restrict abortion access during the pandemic, clinics may find it financially untenable to stay open in light of reduced client caseloads. For one-third of the nation's abortion clinics, the majority of patient visits are for health care services such as contraception, general gynecological care, and STI testing and treatment. 6 Visits for these purposes may decline because people do not want to risk exposure to the coronavirus by visiting a health care provider. These facilities may experience reduced patient visits to an extent that it threatens their financial stability and, as a result, people in these communities will lose access not just to abortion, but to the full range of sexual and reproductive health care. It is heartening that a number of states have taken the initiative during the COVID-19 crisis to explicitly acknowledge and affirm that abortion is essential health care. Governors in 12 states-California, Hawaii, Illinois, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, New York, Oregon and Virginiahave taken an even more proactive stance by issuing executive orders stating that essential (or exempt) medical services include abortion and, in many of these states, family planning services. These orders recognize that contraceptives, STI testing and treatment, and other types of sexual and reproductive health care remain essential during a health care crisis. Nonetheless, there is room for improvement. In Great Britain, the Department of Health and Social Care announced that mifepristone and misoprostol-the pills used for medication abortion-can be mailed to individuals so they do not have to travel to a clinic. 24 (Notably, this provision is limited to the duration of the pandemic or up to two years.) There have been more modest efforts to move in this direction in the United States. A clinical trial that was underway before the pandemic struck allows the mail-order pharmacy dispensing of mifepristone and misoprostol. 25 Moreover, a coalition of 21 state attorneys general, as well as Senators Elizabeth Warren, Patty Murray and Tammy Baldwin, have requested that the Food and Drug Administration remove unnecessary restrictions on mifepristone so that it can be mailed or dispensed through online pharmacies in the absence of a clinical trial. Some of the evidence-based changes in abortion care that are being implemented during the pandemic may improve access to and quality of abortion care in the long term-at least among the abortion clinics that are able to remain open. Many facilities have rapidly adopted new practices that allow them to reduce the risk of exposure to coronavirus in health care settings. These include interventions such as foregoing blood draws and ultrasounds when medically appropriate to do so and allowing patients to make abortion follow-up visits via phone or video. 7 Maintaining these changes in protocol after the pandemic has passed could lead to care that is more accessible and patient-centered. Bans on abortion, however, are not based on evidence for COVID-19 mitigation and are in opposition to prevailing medical and public health guidance. Indeed, denying pregnant people who want and need abortions could place them at greater risk for COVID-19 by forcing them to travel much farther (which runs counter to social distancing requirements in many states) or to continue their pregnancy (which necessitates more interaction with the health care system). For each month that the pandemic continues, it is estimated that 71,000 people may seek abortion care in the United States. 6 Abortion is a common, time-sensitive, essential health care service that must remain accessible during this-and potential future-pandemics. The U.S. health care system has both the expertise and the means to safely provide this care. What is needed now is the political will and evidence-based understanding among those leading the nation's COVID-19 mitigation efforts-including governors, public health departments, and the Food and Drug Administration-to ensure that abortion care remains accessible and safe for everyone. Restricted access to abortion violates human rights, precludes reproductive justice, and demands public health intervention Joint statement on abortion access during the COVID-19 outbreak Characteristics and circumstances of U.S. women who obtain very early and second-trimester abortions The comparative safety of legal induced abortion and childbirth in the United States AMA statement on government interference in reproductive health care Abortion Incidence and Service Availability in the United States Medication abortion: a sample protocol for increasing access during a pandemic and beyond Change in abortion services after implementation of a restrictive law in Texas A 21st-century public health approach to abortion COVID-19 abortion bans would greatly increase driving distances for those seeking care Population group abortion rates and lifetime incidence of abortion: United States Travel for abortion services in Alabama and delays obtaining care, Women's Health Issues Experiences of women who travel for abortion: a mixed methods systematic review Impact of clinic closures on women obtaining abortion services after implementation of a restrictive law in Texas Change in distance to nearest facility and abortion in Texas Change in second-trimester abortion after implementation of a restrictive state law Understanding why women seek abortions in the US The economic consequences of being denied an abortion Socioeconomic outcomes of women who receive and women who are denied wanted abortions in the United States Side effects, physical health consequences, and mortality associated with abortion and birth after an unwanted pregnancy, Women's Health Issues Risk of violence from the man involved in the pregnancy after receiving or being denied an abortion Charlotte abortion protest arrests under NC stay-at-home order 'unconstitutional,' Charlotte Observer Texas women's decisions and experiences regarding selfmanaged abortion Coronavirus (COVID-19) Infection and Abortion Care TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States We thank our colleagues Megan Donovan, Joerg Dreweke, Liza Fuentes, Kathryn Kost and Elizabeth Nash, all of the Guttmacher Institute, for providing feedback on early versions of this manuscript. The research and writing of this viewpoint did not rely on any external funding. Author contact: rjones@guttmacher.org Author biographies: Rachel K. Jones and Laura Lindberg are principal research scientists, and Elizabeth Witwer is research associate, all at the Guttmacher Institute, New York.